Can Last Week’s Winners Anglo American plc, Acacia Mining PLC & Hikma Pharmaceuticals PLC Keep Charging?

Royston Wild discusses the investment case for Anglo American plc (LON: AAL), Hikma Pharmaceuticals Plc (LON: HIK) & Acacia Mining PLC (LON: ACA).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at the investment prospects of three recent FTSE risers.

Stop digging!

Shares in mining goliath Anglo American (LSE: AAL) have stabilised since the start of January thanks to a solid uptick in the iron ore price. Many investors are speculating that the bottom has finally been ploughed, while extra US dollar weakness and a cancellation of ‘short’ positions has also sent shares in Anglo American hurtling skywards during the past week.

I’m convinced this strength presents nothing more than a fresh selling opportunity, however. Sure, iron ore prices may have received a welcome uptick more recently. But with Chinese economic cooling still accelerating, and domestic steelmaking activity sinking as the construction sector struggles, I reckon Anglo American’s surge is likely to peter out.

The London business is aggressively downscaling its operations to mitigate a poor earnings outlook, from ramping up cost savings and capex reductions to slashing around 60% of its asset base. But while wise in the current climate of falling commodity values, massive project sales are likely to seriously constrain profits growth once supply/demand imbalances eventually improve.

A medical marvel

Medicines giant Hikma Pharmaceuticals (LSE: HIK) had cause for further cheer last week as its share price continued to ignite. To say that the healthcare play has been volatile in recent months would be something of a colossal understatement, and I believe further turbulence can be expected in the weeks ahead as market sentiment shakes.

But in the long term I believe Hikma will prove a lucrative stock selection as earnings appear on course to surge.

All has not been rosy in the garden in recent times as weak demand for its Generics products forced the business to cut its full-year profit expectations for last year. Still, investors should be hugely confident in Hikma’s accelerating progress across the Middle East and North Africa, regions where healthcare spend continues to head higher.

And acquisitions like that of US-based Roxane Laboratories for $2.65bn last year are also bolstering the firm’s already-hot product pipeline, not to mention turbocharging its exposure to other white-hot geographies and product areas. I fully expect sales to explode at Hikma in the years ahead.

Gold bounce set to last?

I’m not so bullish over the long-term prospects of gold producer Acacia Mining (LSE: ACA) however, thanks to the fragile outlook for metal prices in 2016 and potentially beyond.

Investor appetite for the so-called ‘hard currency’ has exploded in recent sessions, a combination of dollar erosion and bubbly safe-haven buying pushing metal values markedly higher. Indeed, gold was dealing just shy of $1,180 per ounce just this morning, its most expensive since October.

Still, steady dollar appreciation put paid to commodity prices in 2015, and I expect these pressures to materialise again in the coming months as currency devaluation across the globe propels the greenback. And further Fed rate hikes can’t be ruled out either, despite poor economic data more recently casting some doubts over the scale of monetary tightening this year.

When you also factor-in a backdrop of low global inflation, not to mention still-weak physical gold demand in Asia, I believe the revenues outlook at Acacia — despite the potential impact of steady production increases — remains on shaky footing.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much would I need to invest in income shares to earn £300 a month?

What kind of lump sum would be required to earn £300 a month by taking advantage of some of the…

Read more »

Investing For Beginners

Up 31% in a month, could this FTSE 250 stock be getting bought out?

Jon Smith takes a look at speculation that's pushing the share price of a FTSE 250 share higher and considers…

Read more »

Investing Articles

Here’s how I’d follow Warren Buffett to start building passive income in 2025

Ben McPoland highlights one FTSE 250 firm with a strong competitive edge that he thinks can continue rewarding investors with…

Read more »

Investing Articles

Burberry shares: undervalued FTSE gems that are ready to rocket?

Burberry shares soared at the beginning of the week as the takeover rumour mill went into overdrive. Is Paul Summers…

Read more »

US Stock

Here are the latest share price forecasts for S&P 500 giant Amazon

Amazon has generated monster gains for investors over the last decade. And Wall Street analysts believe the S&P 500 stock…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

2 high-yield FTSE 250 shares I’d buy today — and 1 that I’d avoid

UK markets have felt some volatility after last week’s Budget and the FTSE 250 was no stranger to it. Our…

Read more »

Investing Articles

3 reasons the Rolls-Royce share price could soar over the next decade

Sustainable aviation fuel, narrow-body aircraft, and small nuclear reactors could all keep the Rolls-Royce share price climbing over the next…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in cheap BT shares

BT shares are on the up but still cheap, while the FTSE 100 telecoms stock offers a good yield too.…

Read more »